NASDAQ$RXST

Rxsight Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Reported financial results for the three months ended September 30, 2021.

RxSight reported Q3 2021 revenue of $5.8 million, a 39% increase compared to Q3 2020. The revenue growth was primarily due to a 55% increase in LDDs sold and a 31% increase in LALs sold. Net loss for the quarter was $(12.7) million, or $(0.68) per share.

  • Achieved third quarter 2021 revenue of $5.8 million, representing growth of 39% compared to the prior year period and 18% growth over the second quarter of 2021.
  • Sold 31 Light Delivery Devices (LDD™s), expanding the installed base to 161 LDDs as of September 30, 2021.
  • Sold 1,977 Light Adjustable Lenses (LAL®s).
  • Completed roll-out of the ActivShield™ LAL, with a UV protection layer built into the lens.

Headline financials

Total Revenue

$5.79M

Previous: $4.17M+38.8%
EPS (adj)

-$0.65

Previous: $1.61-140.4%
Capital Expenditures

-$1.58M

No prior period
Free Cash Flow

-$14.2M

No prior period
Net Income

-$12.7M

Previous: $30.7M-141.3%
Operating Income

-$13.1M

Previous: -$8.91M-47.2%
Gross Profit

$1.34M

Previous: $720K+86.3%
Cash & Equivalents

$68.3M

No prior period
Total Assets

$204M

No prior period
Stock-Based Comp

$2.01M

No prior period

Revenue & EPS history

Rxsight · Revenue · Quarterly

$5.79M

Q3 2021+38.8%vs Q3 2020
Beat estimate in 6 of 11 quarters(55%)
ActualEstimate

Revenue by segment

Rxsight · $11.4M total across 2 segments · Q2 2022

  • LAL Revenue
    $5.8M
  • LDD Revenue
    $5.6M

Forward guidance

RxSight projects 2021 full year revenue to be between $21.0 million and $21.4 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-1.1%

Avg return

Earnings day

-2.6%

Avg return

5 days after

+2.8%

Avg return

30 days after

45%

9 / 20 earnings

Positive

+15.1%

Q3 2022

Best reaction

-16.1%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-6.6%-21.6%-31.1%
Q4 2025-10.1%-13.5%-28.9%
Q3 2025+8.7%+16.3%+46.7%
Q1 2025-11.2%-11.4%+0.9%
Q4 2024-0.8%-7.8%-9.1%
Q3 2024-12.3%-16.9%-21.2%
Q2 2024+14.6%+21.5%+29.0%
Q1 2024+0.8%-3.8%-5.0%
Q4 2023-5.8%-3.2%-10.9%
Q3 2023+1.8%+9.5%+40.8%
Q2 2023-1.5%-6.3%-1.8%
Q1 2023+9.0%+18.3%+34.0%
Q4 2022+9.7%+4.5%+17.9%
Q3 2022+15.1%+14.6%+18.1%
Q2 2022-2.9%-8.3%-13.3%
Q1 2022-4.3%-3.0%+34.9%
Q4 2021+1.4%-3.2%+1.8%
Q3 2021+3.7%-0.8%-4.0%
Q4 2020-16.1%-18.4%-21.1%
Q2 2021-16.1%-18.4%-21.1%
Q1 2021
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro